Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2020

01-12-2020 | Erythromycin | Research

Prevalence, risk factors, phenotypic and molecular characteristics for Staphylococcus aureus carriage in community-based drug users in Guangzhou, China

Authors: Yingying Wang, Jialing Lin, Junli Zhou, Zhigang Han, Zhenjiang Yao

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2020

Login to get access

Abstract

Background

Staphylococcus aureus (S. aureus), particularly methicillin-resistant Staphylococcus aureus (MRSA), remains the predominant cause of infections in drug users. This cross-sectional study aims to elucidate the prevalence, risk factors, phenotypic and molecular characteristics of S. aureus carriage among community-based drug users.

Methods

All eligible drug users, with both injection and non-injection route of drug administration, were asked to complete questionnaires and collect nasal swabs by trained personal during the period between May and December 2017 in Guangzhou, China. Swabs were processed for identification of S. aureus. Antimicrobial susceptibility test and polymerase chain reaction assays were used to detect phenotypic and molecular characteristics for identified isolates. Univariate and multivariate logistic regression analyses were used to assess risk factors for S. aureus carriage.

Results

Overall, 353 drug users were included in the study and the prevalence of S. aureus carriage was 15.01% (53/353). The prevalence of MRSA carriage was 6.80% (24/353). Cohabitation was a risk factor for S. aureus (adjusted OR = 8.80, 95% CI: 1.89–40.99). The proportion of multidrug resistance was 54.72% for S. aureus isolates and most of these isolates were resistant to penicillin, erythromycin and clindamycin. Seventeen MRSA isolates were multidrug resistant. The results of clonal complexes (CCs) and sequence types (STs) for S. aureus were diverse. The three predominant types for CCs were CC5 (64.15%, 34/53), CC59 (11.32%, 6/53), and CC7 (7.55%, 4/53); and for STs were ST188 (20.75%, 11/53), ST5 (11.32%, 6/53), and ST59 (11.32%, 6/53).

Conclusion

The prevalence of S. aureus nasal carriage was lower while the prevalence of MRSA carriage was moderate compared to previous studies. Phenotypic and molecular characteristics of S. aureus isolates, particularly MRSA isolates, revealed high proportions of antibiotic resistance, indicating the existence of cross-circulation, and implying high opportunity of virulence-related diseases. Decolonization and antibiotic stewardship might be implemented for drug users with MRSA carriage.
Literature
1.
go back to reference Paterson GK, Harrison EM, Holmes MA. The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2014;22:42–7.CrossRef Paterson GK, Harrison EM, Holmes MA. The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2014;22:42–7.CrossRef
2.
go back to reference Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–62.CrossRef Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–62.CrossRef
4.
go back to reference Leung NS, Padgett P, Robinson DA, Brown EL. Prevalence and behavioural risk factors of Staphylococcus aureus nasal colonization in community-based injection drug users. Epidemiol Infect. 2015;143:2430–9.CrossRef Leung NS, Padgett P, Robinson DA, Brown EL. Prevalence and behavioural risk factors of Staphylococcus aureus nasal colonization in community-based injection drug users. Epidemiol Infect. 2015;143:2430–9.CrossRef
5.
go back to reference El-Sharif A, Ashour HM. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers. Exp Biol Med (Maywood). 2008;233:874–80.CrossRef El-Sharif A, Ashour HM. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers. Exp Biol Med (Maywood). 2008;233:874–80.CrossRef
6.
go back to reference Lin J, Liang J, Zhang T, Bai C, Ye J, Yao Z. Dose-response associations of methicillin-resistant Staphylococcus aureus between school environmental contamination and nasal carriage by elementary students. Infect Drug Resist. 2018;11:773–82.CrossRef Lin J, Liang J, Zhang T, Bai C, Ye J, Yao Z. Dose-response associations of methicillin-resistant Staphylococcus aureus between school environmental contamination and nasal carriage by elementary students. Infect Drug Resist. 2018;11:773–82.CrossRef
7.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRef Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRef
8.
go back to reference Al-Rawahi GN, Schreader AG, Porter SD, Roscoe DL, Gustafson R, Bryce EA. Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. J Clin Microbiol. 2008;46:477–9.CrossRef Al-Rawahi GN, Schreader AG, Porter SD, Roscoe DL, Gustafson R, Bryce EA. Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. J Clin Microbiol. 2008;46:477–9.CrossRef
9.
go back to reference Gwizdala RA, Miller M, Bhat M, Vavagiakis P, Henry C, Neaigus A, Shi Q, Lowy FD. Staphylococcus aureus colonization and infection among drug users: identification of hidden networks. Am J Public Health. 2011;101:1268–76.CrossRef Gwizdala RA, Miller M, Bhat M, Vavagiakis P, Henry C, Neaigus A, Shi Q, Lowy FD. Staphylococcus aureus colonization and infection among drug users: identification of hidden networks. Am J Public Health. 2011;101:1268–76.CrossRef
10.
go back to reference Bassetti S, Wolfisberg L, Jaussi B, Frei R, Kuntze MF, Battegay M, Widmer AF. Carriage of Staphylococcus aureus among injection drug users: lower prevalence in an injection heroin maintenance program than in an oral methadone program. Infect Control Hosp Epidemiol. 2004;25:133–7.CrossRef Bassetti S, Wolfisberg L, Jaussi B, Frei R, Kuntze MF, Battegay M, Widmer AF. Carriage of Staphylococcus aureus among injection drug users: lower prevalence in an injection heroin maintenance program than in an oral methadone program. Infect Control Hosp Epidemiol. 2004;25:133–7.CrossRef
11.
go back to reference Quagliarello B, Cespedes C, Miller M, Toro A, Vavagiakis P, Klein RS, Lowy FD. Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis. 2002;35:671–7.CrossRef Quagliarello B, Cespedes C, Miller M, Toro A, Vavagiakis P, Klein RS, Lowy FD. Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis. 2002;35:671–7.CrossRef
12.
go back to reference Miller M, Cespedes C, Vavagiakis P, Klein RS, Lowy FD. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis. 2003;22:463–9.CrossRef Miller M, Cespedes C, Vavagiakis P, Klein RS, Lowy FD. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis. 2003;22:463–9.CrossRef
13.
go back to reference Fleisch F, Zbinden R, Vanoli C, Ruef C. Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clin Infect Dis. 2001;32:581–6.CrossRef Fleisch F, Zbinden R, Vanoli C, Ruef C. Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clin Infect Dis. 2001;32:581–6.CrossRef
14.
go back to reference Dahlman D, Jalalvand F, Blome MA, Hakansson A, Janson H, Quick S, Nilsson AC. High Perineal and overall frequency of Staphylococcus aureus in people who inject drugs, compared to non-injectors. Curr Microbiol. 2017;74:159–67.CrossRef Dahlman D, Jalalvand F, Blome MA, Hakansson A, Janson H, Quick S, Nilsson AC. High Perineal and overall frequency of Staphylococcus aureus in people who inject drugs, compared to non-injectors. Curr Microbiol. 2017;74:159–67.CrossRef
15.
go back to reference Chen B, Dai X, He B, Pan K, Li H, Liu X, Bao Y, Lao W, Wu X, Yao Y, Huang S. Differences in Staphylococcus aureus nasal carriage and molecular characteristics among community residents and healthcare workers at Sun Yat-Sen University, Guangzhou, Southern China. BMC Infect Dis. 2015;15:303.CrossRef Chen B, Dai X, He B, Pan K, Li H, Liu X, Bao Y, Lao W, Wu X, Yao Y, Huang S. Differences in Staphylococcus aureus nasal carriage and molecular characteristics among community residents and healthcare workers at Sun Yat-Sen University, Guangzhou, Southern China. BMC Infect Dis. 2015;15:303.CrossRef
16.
go back to reference Ganesh R, Castle D, McGibbon D, Phillips I, Bradbeer C. Staphylococcal carriage and HIV infection. Lancet. 1989;2:558.CrossRef Ganesh R, Castle D, McGibbon D, Phillips I, Bradbeer C. Staphylococcal carriage and HIV infection. Lancet. 1989;2:558.CrossRef
17.
go back to reference Fleisch F, Oechslin EC, Gujer AR, Ritzler E, Imhof A, Ruef C, Reinhart WH. Transregional spread of a single clone of methicillin-resistant Staphylococcus aureus between groups of drug users in Switzerland. Infect. 2005;33:273–7.CrossRef Fleisch F, Oechslin EC, Gujer AR, Ritzler E, Imhof A, Ruef C, Reinhart WH. Transregional spread of a single clone of methicillin-resistant Staphylococcus aureus between groups of drug users in Switzerland. Infect. 2005;33:273–7.CrossRef
18.
go back to reference Lloyd-Smith E, Hull MW, Tyndall MW, Zhang R, Wood E, Montaner JS, Kerr T, Romney MG. Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. Epidemiol Infect. 2010;138:713–20.CrossRef Lloyd-Smith E, Hull MW, Tyndall MW, Zhang R, Wood E, Montaner JS, Kerr T, Romney MG. Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. Epidemiol Infect. 2010;138:713–20.CrossRef
19.
go back to reference Lee CH, Tsai CY, Li CC, Chien CC, Liu JW. Teicoplanin therapy for MRSA bacteraemia: a retrospective study emphasizing the importance of maintenance dosing in improving clinical outcomes. J Antimicrob Chemother. 2015;70:257–63.CrossRef Lee CH, Tsai CY, Li CC, Chien CC, Liu JW. Teicoplanin therapy for MRSA bacteraemia: a retrospective study emphasizing the importance of maintenance dosing in improving clinical outcomes. J Antimicrob Chemother. 2015;70:257–63.CrossRef
20.
go back to reference Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother. 2009;53:4069–79.CrossRef Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother. 2009;53:4069–79.CrossRef
21.
go back to reference Wiedemann K, Schmid C, Hamm H, Wirbelauer J. Staphylococcal scalded skin syndrome in a very low birth weight premature infant. Z Geburtshilfe Neonatol. 2016;220:35–8.CrossRef Wiedemann K, Schmid C, Hamm H, Wirbelauer J. Staphylococcal scalded skin syndrome in a very low birth weight premature infant. Z Geburtshilfe Neonatol. 2016;220:35–8.CrossRef
22.
go back to reference Layer F, Sanchini A, Strommenger B, Cuny C, Breier AC, Proquitte H, Buhrer C, Schenkel K, Batzing-Feigenbaum J, Greutelaers B, et al. Molecular typing of toxic shock syndrome toxin-1-and enterotoxin A-producing methicillin-sensitive Staphylococcus aureus isolates from an outbreak in a neonatal intensive care unit. Int J Med Microbiol. 2015;305:790–8.CrossRef Layer F, Sanchini A, Strommenger B, Cuny C, Breier AC, Proquitte H, Buhrer C, Schenkel K, Batzing-Feigenbaum J, Greutelaers B, et al. Molecular typing of toxic shock syndrome toxin-1-and enterotoxin A-producing methicillin-sensitive Staphylococcus aureus isolates from an outbreak in a neonatal intensive care unit. Int J Med Microbiol. 2015;305:790–8.CrossRef
23.
go back to reference Udo EE, Al-Bustan MA, Jacob LE, Chugh TD. Enterotoxin production by coagulase-negative staphylococci in restaurant workers from Kuwait City may be a potential cause of food poisoning. J Med Microbiol. 1999;48:819–23.CrossRef Udo EE, Al-Bustan MA, Jacob LE, Chugh TD. Enterotoxin production by coagulase-negative staphylococci in restaurant workers from Kuwait City may be a potential cause of food poisoning. J Med Microbiol. 1999;48:819–23.CrossRef
24.
go back to reference Lin J, Wu C, Yan C, Ou Q, Lin D, Zhou J, Ye X, Yao Z. A prospective cohort study of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus carriage in neonates: the role of maternal carriage and phenotypic and molecular characteristics. Infect Drug Resist. 2018;11:555–65.CrossRef Lin J, Wu C, Yan C, Ou Q, Lin D, Zhou J, Ye X, Yao Z. A prospective cohort study of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus carriage in neonates: the role of maternal carriage and phenotypic and molecular characteristics. Infect Drug Resist. 2018;11:555–65.CrossRef
25.
go back to reference Monecke S, Ehricht R, Slickers P, Wiese N, Jonas D. Intra-strain variability of methicillin-resistant Staphylococcus aureus strains ST228-MRSA-I and ST5-MRSA-II. Eur J Clin Microbiol Infect Dis. 2009;28:1383–90.CrossRef Monecke S, Ehricht R, Slickers P, Wiese N, Jonas D. Intra-strain variability of methicillin-resistant Staphylococcus aureus strains ST228-MRSA-I and ST5-MRSA-II. Eur J Clin Microbiol Infect Dis. 2009;28:1383–90.CrossRef
26.
go back to reference Wu D, Li X, Yang Y, Zheng Y, Wang C, Deng L, Liu L, Li C, Shang Y, Zhao C, et al. Superantigen gene profiles and presence of exfoliative toxin genes in community-acquired meticillin-resistant Staphylococcus aureus isolated from Chinese children. J Med Microbiol. 2011;60:35–45.CrossRef Wu D, Li X, Yang Y, Zheng Y, Wang C, Deng L, Liu L, Li C, Shang Y, Zhao C, et al. Superantigen gene profiles and presence of exfoliative toxin genes in community-acquired meticillin-resistant Staphylococcus aureus isolated from Chinese children. J Med Microbiol. 2011;60:35–45.CrossRef
27.
go back to reference Mediavilla JR, Chen L, Mathema B, Kreiswirth BN. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol. 2012;15:588–95.CrossRef Mediavilla JR, Chen L, Mathema B, Kreiswirth BN. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol. 2012;15:588–95.CrossRef
28.
go back to reference Yu F, Li T, Huang X, Xie J, Xu Y, Tu J, Qin Z, Parsons C, Wang J, Hu L, Wang L. Virulence gene profiling and molecular characterization of hospital-acquired Staphylococcus aureus isolates associated with bloodstream infection. Diagn Microbiol Infect Dis. 2012;74:363–8.CrossRef Yu F, Li T, Huang X, Xie J, Xu Y, Tu J, Qin Z, Parsons C, Wang J, Hu L, Wang L. Virulence gene profiling and molecular characterization of hospital-acquired Staphylococcus aureus isolates associated with bloodstream infection. Diagn Microbiol Infect Dis. 2012;74:363–8.CrossRef
29.
go back to reference Soge OO, No D, Michael KE, Dankoff J, Lane J, Vogel K, Smedley J, Roberts MC. Transmission of MDR MRSA between primates, their environment and personnel at a United States primate Centre. J Antimicrob Chemother. 2016;71:2798–803.CrossRef Soge OO, No D, Michael KE, Dankoff J, Lane J, Vogel K, Smedley J, Roberts MC. Transmission of MDR MRSA between primates, their environment and personnel at a United States primate Centre. J Antimicrob Chemother. 2016;71:2798–803.CrossRef
30.
go back to reference Cuny C, Köck R, Witte W. Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany. Int J Med Microbiol. 2013;303:331–7.CrossRef Cuny C, Köck R, Witte W. Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany. Int J Med Microbiol. 2013;303:331–7.CrossRef
31.
go back to reference Garcia-Graells C, Antoine J, Larsen J, Catry B, Skov R, Denis O. Livestock veterinarians at high risk of acquiring methicillin-resistant Staphylococcus aureus ST398. Epidemiol Infect. 2011;140:383–9.CrossRef Garcia-Graells C, Antoine J, Larsen J, Catry B, Skov R, Denis O. Livestock veterinarians at high risk of acquiring methicillin-resistant Staphylococcus aureus ST398. Epidemiol Infect. 2011;140:383–9.CrossRef
32.
go back to reference Huang SS, Singh R, McKinnell JA, Park S, Gombosev A, Eells SJ, Gillen DL, Kim D, Rashid S, Macias-Gil R, et al. Decolonization to reduce Postdischarge infection risk among MRSA carriers. N Engl J Med. 2019;380:638–50.CrossRef Huang SS, Singh R, McKinnell JA, Park S, Gombosev A, Eells SJ, Gillen DL, Kim D, Rashid S, Macias-Gil R, et al. Decolonization to reduce Postdischarge infection risk among MRSA carriers. N Engl J Med. 2019;380:638–50.CrossRef
Metadata
Title
Prevalence, risk factors, phenotypic and molecular characteristics for Staphylococcus aureus carriage in community-based drug users in Guangzhou, China
Authors
Yingying Wang
Jialing Lin
Junli Zhou
Zhigang Han
Zhenjiang Yao
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2020
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-020-0698-9

Other articles of this Issue 1/2020

Antimicrobial Resistance & Infection Control 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.